Completed NA INTERVENTIONAL 1-arm NCT02884622

DNA Methylation and Lung Disease in Cystic Fibrosis (METHYLCF)

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Interventions Blood sampling nasal epithelial

Updated 5 times since 2017 Last updated: Aug 30, 2016 Started: Jun 30, 2013 Primary completion: Jun 30, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02884622, this NA trial focuses on Cystic Fibrosis and remains completed. Sponsored by Institut National de la Santé Et de la Recherche Médicale, France, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut National de la Santé Et de la Recherche Médicale, France
University Hospital, Montpellier
Vaincre la Mucoviscidose

Data source: University Hospital, Montpellier

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montpellier, France